ACEA Biosciences, Inc., a developer of advanced microelectronic systems for cell-based assays, is profiled in the January, 2007 issue of "Bioscience Technology." The article, entitled "Biology for the Information Age: Cell Based Assays - Creating High Content from Cells," details the growing use of cell-based assays in life science research, and the shift away from conventional biochemical and in vitro assays. As Dr. James O'Connell, ACEA Biosciences CEO noted in the article, "The sooner you get in a cell-based assay the more likely you are to get biologically relevant information." The article focuses on a number of new technologies being used in the development of high-content, cell-based assays, including ACEA's label-free, real-time microelectronic technology, and details new applications for cell-based assays such as personalized medicine and drug development. Commenting on the article, Dr. Xiaobo Wang, ACEA Bioscience Vice President of Research and CTO stated "we have always believed that cell-based assays provide the scientific researcher with a wealth of information simply not available with other assays. We have worked hard at ACEA to develop a system that simplifies the sometimes difficult task of developing cell-based assays, and, perhaps more importantly, accurately monitoring the assay from start to finish. Our electronic sensors provide continuous, quantitative information concerning the biological status of the cells being used in the assay. All changes to the biological status of the cells are measured automatically and in real time by the RT-CES® system. This is a great benefit to the user."

Founded in 2001, San Diego-based ACEA Biosciences has pioneered the development of high-performance microelectronic systems for cell-based assays. ACEA has developed and is marketing on a world-wide basis its microtiter-plate based biosensor platform for a variety of applications in drug development, toxicology, cancer research, and medical microbiology and virology. ACEA's products are designed to meet the increasing needs of the life science research and drug discovery markets by providing cost-effective, automated, high content, real time microelectronic systems that simplify complex cell-based assay procedures and increase productivity.